About
Lubris BioPharma develops recombinant human lubricin-based biopharmaceutical therapies for treating dry eye disease, osteoarthritis, and other inflammation-related conditions.
Explore Lubris BioPharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.